INOVIO (NASDAQ: INO) released its financial results and operational highlights for 2024, marking significant strides in its ...

Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...

TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals ...

The BLA is reportedly mulling launching a major attack on the China-Pakistan Economic Corridor (CPEC) being developed in ...

The Balochistan Liberation Army (BLA) is eyeing the nuclear weapons of Pakistan after giving a jolt by hijacking the Jaffar Express which claimed several lives in the incident. The Pakistan Army and ...

The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.

After two days of intense military operations, 33 attackers were killed, and 26 passengers — including 18 army and FC ...

INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

While data on functional endpoints are still to come, Avidity Biosciences Inc. executives said the firm is moving ahead with ...

At least 21 passengers were killed in last week's hijacking of a train in Pakistan. A militant group claimed responsibility for blowing up the tracks and opening fire when the train was halfway ...

The Baloch Liberation Army (BLA) claims that 90 Pakistani army personnel were killed during their ambush on Sunday against ...